ArticleAnnals of hematology2021

Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.

Esther Schuler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.